Minerva Minerva

Minerva

BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7330.180 (Published 19 January 2002) Cite this as: BMJ 2002;324:180

Finding an antihypertensive drug that suits the individual not only improves compliance but in some people could be critical for the safety of other people. Losartan, an angiotensin II blocker, came up trumps among aircrew taking part in a placebo controlled, double blind comparison with a calcium channel blocker and an antihistamine. Unlike all the other drugs in the trial, losartan made no difference to performance or measures of sleepiness (Aviation, Space and Environmental Medicine 2001;72:1096-101).

Receiving a false positive result in screening programmes has undesirable results. One month before the next screening round was due, women who had been given the “all clear” (after having had abnormal results on mammography and being referred for more tests three years earlier) remained significantly more anxious than those who had previously had a normal result. This was sufficient to deter 15% of them from attending at all next time around (Journal of Public Health Medicine 2001;23:292-300).

Although alcohol consumption is a causative factor in head and neck cancers, drinking is apparently significantly associated with better physical functioning and an improved quality of …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe